Cliff Sosin's position in Cardlytics is currently worth $88.9 Million. That's 11.48% of their entire equity portfolio (4th largest holding). The investor owns 15.82% of the outstanding Cardlytics stock. Cliff Sosin acquired their 5.42 Million shares between 2019 and 2022. So far they never sold any shares in the company. The investor's estimated purchase price is $278 Million, resulting in a loss of 68%.